If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
IAEA Human Health Series No. 30
English STI/PUB/1670 ¦ 978-92-0-107214-6
97 pages ¦ 21 figures ¦ € 45.00 ¦ Date published: 2015Brachytherapy is an essential component of the curative treatment of cervical cancer, a disease with high incidence in many developing countries. The IAEA supports the use of high dose rate (HDR) brachytherapy for centres with a large number of patients with this disease. HDR brachytherapy is also used in other common cancers such as breast, lung, oesophagus and prostate cancer. This publication provides guidance to radiation oncologists, medical physicists and planners on establishing and operating an HDR brachytherapy unit with modern standards, and presents the main issues to be addressed for its effective and safe operation.
More Information on reusing IAEA copyright material.
Orders and requests for information may also be addressed to:
Publishing Section
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,
Austria
Tel.: +43 1 2600 22529, +43 1 2600 22530
Email: sales.publications@iaea.org
